Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes.
暂无分享,去创建一个
R. Hamman | D. Pettitt | B. Linder | G. Imperatore | S. Marcovina | D. Dabelea | C. Pihoker | E. Mayer‐Davis | Ralph B. D'Agostino | Dana Dabelea | L. M. Dolan | Teresa A Hillier | Andrea M Ruggiero | Teresa A. Hillier
[1] T. Wilkin. Testing the Accelerator Hypothesis: Body Size, β-Cell Function, and Age at Onset of Type 1 (Autoimmune) Diabetes , 2006, Diabetes Care.
[2] J. Meigs,et al. Race Differences in Long-Term Diabetes Management in an HMO , 2005, Diabetes Care.
[3] O. Kordonouri,et al. Higher body weight is associated with earlier onset of Type 1 diabetes in children: confirming the ‘Accelerator Hypothesis’ , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[4] T. Reinehr,et al. The ‘accelerator hypothesis’: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus , 2005, Diabetologia.
[5] T. Wilkin,et al. Increasing body weight predicts the earlier onset of insulin‐dependant diabetes in childhood: testing the ‘accelerator hypothesis’ (2) , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[6] L. Heding. Radioimmunological determination of human C-peptide in serum , 1975, Diabetologia.
[7] M. Tsuang,et al. The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall , 2004, Schizophrenia Research.
[8] L. Harrison,et al. Insulin resistance is a risk factor for progression to Type 1 diabetes , 2004, Diabetologia.
[9] T. Barrett,et al. Braking the Accelerator Hypothesis? , 2004, Diabetologia.
[10] B. Metcalf,et al. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. , 2003, Diabetes care.
[11] L. Råstam,et al. Increasing body mass index at diagnosis of diabetes in young adult people during 1983–1999 in the Diabetes Incidence Study in Sweden (DISS) , 2003, Journal of internal medicine.
[12] S. Arslanian,et al. Type 2 Diabetes in Childhood: The American Perspective , 2003, Hormone Research in Paediatrics.
[13] M. Rewers,et al. Predictors of acute complications in children with type 1 diabetes. , 2002, JAMA.
[14] L. Nyström,et al. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0–34 years group in Sweden 1983 to 1998 , 2002, Diabetologia.
[15] Raoul Rooman,et al. The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation. , 2002, Diabetes care.
[16] Shumei S. Guo,et al. 2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.
[17] D. Pipeleers,et al. - to: T. J. Wilkin (2001) The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914–921 , 2002, Diabetologia.
[18] E. Robinson,et al. The changing presentation of children with newly diagnosed type 1 diabetes mellitus , 2001, Pediatric diabetes.
[19] P. Magnus,et al. Diabetes-associated HLA-DQ genes and birth weight. , 2001, Diabetes.
[20] M. Donath,et al. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. , 2001, Diabetes.
[21] T. Wilkin. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes , 2001, Diabetologia.
[22] J. Tuomilehto,et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.
[23] C. Boitard,et al. Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial , 2000, The Lancet.
[24] A. T. N. Group,et al. No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII) , 2000, Diabetologia.
[25] Å. Lernmark,et al. Evaluation of a novel radioimmunoassay using125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies , 2000, International journal of clinical & laboratory research.
[26] K. Flegal,et al. The obesity epidemic in children and adults: current evidence and research issues. , 1999, Medicine and science in sports and exercise.
[27] J. Couper,et al. Low-Birth-Weight Infants Show Earlier Onset of IDDM , 1994, Diabetes Care.
[28] D. Pipeleers,et al. Glucose regulation of the autoantigen GAD65 in human pancreatic islets. , 1992, The Journal of clinical endocrinology and metabolism.